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Abstract
Background and Review of Literature: Worldwide heart failure (HF) prevalence rates
are steadily increasing at a high magnitude. With rates of mortality and morbidity high for those
diagnosed with HF, patients are often faced with a poor prognosis. Management of the disease
that is in accordance with the most recent recommended guidelines has been shown to reduce
exacerbations that require hospitalizations and thereby preserving patient quality of life and life
expectancy.
Purpose: The purpose of this project was to decrease hospital readmissions for HF exacerbations
in the primary care setting through improving practitioner and patient adherence to the current
HF treatment guidelines.
Methods: This quality improvement project was designed as a process improvement project. In
order to collect data a pre-intervention/post-intervention project design was used. A selfdeveloped Heart Failure Management Checklist and Likert Survey were utilized to collect data.
Results: Descriptive statistical analysis showed a significant improvement, in most cases >15%,
in the management of heart failure patients, when providers utilized the Heart Failure Checklist
as a tool to adhere to the most current practice guidelines and recommendations.
Conclusion: Primary care providers should have greater access to HF guidelines and the use of
HF succinct checklist in an effort to bridge the gap in knowledge between themselves and
cardiologists and to improve HF patient outcomes. This project attempted to bridge this gap
through a succinct checklist underlining the most current HF treatment recommendations.

Keywords: Heart failure, hospitalizations, readmission, practice guidelines
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Heart Failure: Effective Collaboration and Education to Reduce Preventable Hospital
Readmissions
Introduction
Heart failure (HF) is a medical condition resulting from the impairment of the ventricle to
fill with or eject blood. It can be caused by disease of the myocardium, pericardium,
endocardium, heart valves, vessels or by metabolic disorder (Colcucci et al., 2018). The
prevalence of HF drastically increases with a patient’s age. Despite an aging population, the
medical therapies currently available to cardiac patients have led to a prolongation of lifespan
(Vasan et al., 2018). The Centers of Disease Control and Prevention (CDC) estimate that nearly
5.7 million Americans are currently diagnosed with HF and projections indicate that prevalence
of HF will increase 43% by 2030 (Schell, 2014; Ziaeian & Fonarow, 2016). Mortality rates for
patients with HF continue to remain unacceptably high, partially due to the need for repeated
hospitalizations and readmissions for diagnosed patients which can become both physically
taxing for the patients, as well as a source of financial drain on the healthcare system (Vasan et
al., 2018).
Background
Heart failure is a clinically complex disease which is largely diagnosed through careful
history and physical examination (Colcucci et al., 2017). There are currently no diagnostic tests
to specifically diagnose HF, in fact, echocardiography and laboratory values such as the plasma
N-terminal pro-brain natriuretic peptide (NT-proBNP) do not provide better accuracy in the
diagnosis of HF exacerbations than clinical examination (Colucci et al., 2018). Rather, these
diagnostic tests serve as a tool in determining severity of HF once a patient is diagnosed.
Comprehensive physical examination techniques can provide evidence of the presence and
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extent of cardiac filling pressure elevation, volume overload, ventricular enlargement, pulmonary
hypertension and reduction in cardiac output” (Colcucci et al., 2018).
Once diagnosed, there are two types of assessment module criteria that are used to
determine the severity and stages of HF, the New York Heart Association (NYHA) functional
class rating and the American College of Cardiology/American Heart Association guidelines for
HF staging (Appendix A). The NYHA classification is used by providers to quantify the level of
functional limitations, based on symptom imposed on a patient diagnosed with HF, while the
other tool provides an objective measure of the evolution of development of the disease process
(American Heart Association, 2017). The NYHA and American College of
Cardiology/American Heart Association staging guidelines are broken down into four
classes/stages which fall in line with one another. Classes are documented as I-IV and stages are
categorized as stage A-D. Class IV and stage D would indicate advanced disease and
interventions, with symptoms present at rest.
There are currently 5.7 million Americans living with a diagnosis of HF, many of which
were diagnosed at age 65 or older (Kim & Han, 2013). The Framingham Heart Survey, an
ongoing long-term cohort cardiovascular study in its third generation, indicated that prevalence
rates of HF increase from 8 per 1000 at age 50-59 years, to 66 per 1000 by ages 80-89 in both
men and women (Framingham Heart Study, 2019; Vasan et al., 2018). In this already fragile
patient population, hospitalizations with a primary diagnosis of HF exacerbation have increased
to over 1 million and 2.4 to 3.6 million with a secondary diagnosis of HF (Kim & Han, 2013).
This data indicates that currently HF exacerbations are one of the leading causes of
hospitalization.
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According to The Centers of Medicare and Medicaid Services (CMS), the annual cost of
HF related hospital readmissions is $17.4 Billion (Kim & Han, 2013). With approximately 23%
of patients with the diagnosis being readmitted within 30 days of discharge and 50% within 6
months, it is clear to see that the outpatient medical management of HF needs improving (Kim &
Han, 2013; Ziaeian & Fonarow, 2016). The Affordable Care Act (ACA) of 2010 currently
imposes a financial penalty for hospital readmissions within 30 days of discharge for Medicare
fee-for-service patients (Bradford et al., 2017). Evidence from research suggests that many
readmissions are preventable and therefore under the ACA if a hospitals readmission rates for
HF are higher than the national average CMS may penalize the hospital the following year
(Bradford et al., 2017).
Focus on lowering preventable HF related hospitalizations not only has positive effects
on the economic burden of the disease, but also on potentially improving patient quality of life.
Evidence-based management interventions, improved multidisciplinary collaboration and
increased patient education have all been determined to reduce patient hospitalizations.
Problem Statement
Patients aged 65 and older with a diagnosis of heart failure (Class I-III and stage A-C) are
at an increased risk for preventable hospitalizations and readmissions as evidenced by
readmission rates of 23% within 30 days and 50% within six months of discharge (Kim & Han,
2013). Preventable hospital readmissions can be reduced through more effective
multidisciplinary collaboration and patient centered education regarding their disease process.
Exacerbations of HF are characterized by patient signs and symptoms, level of vascular and
pulmonary congestion and diagnostic laboratory values (I. Davis, personal communication, April
29, 2020). Stage D and Class IV patients were excluded due to the advanced stage of their
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disease process. This process improvement project attempted to bridge the gap between
management guidelines and practice, through the use of a heart failure checklist, thereby
reducing the amount of preventable hospitalizations.
Organizational “Gap” Analysis of Project Site
This capstone project was carried out in a primary care setting. A 1997 landmark study
by Edep et al. determined that there is a significant difference in the management of HF between
cardiologists and primary care providers. It was determined that cardiologists practice more in
line with the current American Heart Association, The American College of Cardiology and The
Heart Failure of America guidelines (Edep et al., 1997). Multidisciplinary collaboration in the
management of care of HF is lacking which can lead to poor outcomes for patients. Primary care
providers, while attempting to manage cardiac patients effectively, may not be knowledgeable of
new changes in practice or the magnitude of resources available to this patient population. This
can be attributed to the way in which new information is disseminated within the medical
community. Cardiology journals are four times more likely to publish information on new
changes in the treatment of HF than family and general practice journals (Edep et al., 1997).
Furthermore, cardiologists are more likely to use diagnostic tests such as
echocardiograms to assess ventricular function and prescribe medications in line with guideline
recommendations at more appropriate doses (Edep et al., 1997). This is an important concept
when determining a gap in practice because many patients that have a diagnosis of HF may not
be following up with cardiology regularly or at all. The primary care practitioner acts as a
provider and facilitator of care and in most cases, they are the first medical professional to be
assessing a patient complaining of HF symptoms. The overall goal for maximum patient benefits
is integrated care amongst all the disciplines that are beneficial in maintaining cardiac health.
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Approximately 50% of patients with a heart failure will die within 5 years of diagnosis (Centers
for Disease Control and Prevention, 2019). Managing and preventing exacerbations at the front
line or primary care level can improve quality of life and life expectancy.
The National Quality Forum has outlined the Joint Commission on Accreditation and
Health Care Organizations (JC) 2014 process measures for the outpatient management of HF.
The six recommendations include; starting the patient on beta blocker therapy, ensuring a post
hospital discharge appointment for HF patients, timely transmission of the care transition record,
initiating a discussion on advance care planning, executing an advanced directive, and a post
discharge evaluation of the patient within 72 hours (National Quality Forum, 2016). Many of
these recommendations will be completed at the primary care level and should involve the
patient and family. However, many patients do not receive appropriate follow up care post
hospitalizations and their outpatient resources are not utilized to the fullest in order to prevent
exacerbations (Casteel, 2012). Ensuring that the primary care provider has a reference to the
most updated HF guidelines can not only prevent exacerbations of non-hospitalized patients, but
also prevent readmissions to recently hospitalized patients.
Review of the Literature
Methods
For the purpose of this review of literature, the healthcare-based databases utilized in
order to find relevant studies were PubMed, The Cumulative Index for Nursing and Allied
Health Literature (CINAHL), and Cochrane Library. Key terms used within the searches
included; congestive heart failure management, heart failure readmission, readmission
prevention for heart failure, hospitalization prevention heart failure and primary care of heart
failure. Inclusion criteria included: full text journal articles, articles published after 2007, written
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in the English language, and articles that focused on the primary care management of HF in
order to prevent hospitalizations/readmissions due to exacerbations of the disease. Exclusion
criteria included studies with a focus on pediatric patients, patients with end stage CHF and
studies that only pertained to transitional care. Studies were screened for topic relevance through
title and abstract screening. Studies that were considered for the review were evaluated using the
hierarchical levels of evidence as presented by Melnyk.
Results
The database searches yielded a broad range of research journal articles and publications
in which PubMed provided the largest quantity (Table 1). One 1997 landmark study by Edep at
al. was included in the review. Twenty-five articles were identified based on the inclusion
criteria. Ten articles were omitted due to content. The journal articles included two level I
systematic review and meta-analysis, one level III cross-sectional study, one level II comparative
prospective study, three level II retrospective studies, one level II retrospective cohort study, one
level III quasi-experimental study, one level IV cohort study, three level V systematic reviews
and one level VI cross sectional study.
Synthesis
Economic burden
High rates of morbidity and mortality along with a high economic burden, mainly due to
hospitalizations, make heart failure a major public health concern (Giezeman, Arne & Theander,
2017). “Congestive heart failure accounts for 3% of admissions to US hospitals, and the
diagnosis carries a mortality rate of 20% at 1 year and 80% at 8 years” (Banerjee & Stafford,
2010). Approximately 5.7 million Americans are presently living with HF, but that number is
expected to rise to 8 million by 2030 indicating an expected increase of 46% in the prevalence
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rate of the diagnosis (Ziaeian & Fonarow, 2016). Worldwide, HF affects 1-2% of the adult
population and over 10% of people over the age of 70 (Giezeman et al., 2017; Smith et al., 2012;
Tung et al., 2016). Hospitalization due to HF exacerbation is not only considered the strongest
predictor of mortality, but also carries with it a large financial consequence (Gheorghiade et al.,
2013; Smith et al., 2012). It is estimated that standard HF related costs for the average insurer are
approximately $8000 per person per year and $12000 per person per year for those who are
hospitalized due to exacerbations (Smith et al., 2012). According to the Centers for Medicare
and Medicaid the American public bears the burden of HF hospitalizations and readmissions to
the tune of over $15-17.4 billion annually on top of the $32 billion it costs the nation in direct
medical care of HF (Bradley et al., 2013; Gheorghiade et al., 2013; Wan et al., 2017).
Disparities in outpatient care
National 30-day readmission rates for HF patients continue to be approximately 25%, a
significantly higher rate when compared to other diagnoses that may require frequent
hospitalizations (Regalbuto et al., 2014; Tung et al., 2016; Wan et al., 2017). Research indicates
that despite ongoing efforts there still remains a gap in the multidisciplinary management of HF
that is inclusive of the patient. Four studies, including one landmark study, had similar findings
in that adherence to HF guidelines and outpatient care in the primary care setting remains
negligible (Banerjee & Stafford, 2010; Edep et al., 1997; Giezeman et al, 2017; Falces et al.,
2011). The data suggests that overall treatment of heart disease was improved in patients that
routinely followed up with a cardiologist (Falce et al., 2011). This is due partly because
cardiologists practice more in line with the American Heart Association (AHA) and the
American College of Cardiology (ACC) evidence-based practice guidelines than do internists
and general family practitioners in the treatment of HF (Edep et al., 1997). Not only do
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cardiologists more frequently use diagnostic tests such as echocardiograms, stress tests and
cardiac catheterizations to diagnose and correct causes of reversible HF, they also more
frequently prescribe medical agents such as digoxin and nitrates which is in line with current
guideline recommendations (Edep et al., 1997; Giezeman et al., 2017).
It is suggested that integration of care should include long-term follow up care by a
cardiologist for ischemic heart disease, heart failure, valve disease and atrial fibrillation, while
the primary care team with support from cardiology can be responsible for the management of
stable patients with HF (Falces et al., 2011). One limitation in this research was that no concrete
definition of “stable” was indicated within the text, therefore the term is open to individual
provider interpretation. This can lead to varying treatment plans and outcomes. In patients with
multiple comorbidities who are not maintained on current levels of medications cardiologist care
should be indicated. Many of the studies indicated that within the primary care setting only a
small fraction of patients receive the recommended targeted doses of their pharmacological
treatments because providers are not comfortable with managing the side effects that these drugs
may induce (Edep et al., 1997; Giezeman et al., 2017; Falces et al., 2011). Therefore,
involvement with a cardiologist in some aspect, whether direct care or through integrative
cardiovascular consult, will improve overall patient outcomes (Edep et al., 1997; Falces et al.,
2011).
Importance of follow up care
While it is evident that routine follow up care is imperative to maintaining health the
frequency at which patients are following up with their primary care providers is declining
(Banerjee & Stafford, 2010). The number of HF related follow up visits has steadily declined
over the past 15 years from 10.9 million in 1994 to 5.7 million in 2008 (Banerjee & Strafford,
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2010). This trend could be indicative of a lack of education that is taking place regarding cardiac
patients’ prognosis and disease process. Interventions inclusive of direct human factors, such as
repeated assessments and follow up care, as well as patient education centered around the HF
disease process, proper nutrition and exercise have shown to have significant positive therapeutic
outcomes on HF patients at risk for repeated hospitalizations (Wan et al., 2017).
Therefore, follow up care in the primary care setting should be in accordance with the
newest cardiac guidelines as well as patient centered. While provider time constraints can limit
the opportunity for patient education the utilization of all available outpatient resources, such as
nutrition services, outpatient HF clinics, telehealth, and nurse based transitional care programs,
can have a drastic effect on hospitalization rates amongst HF patients (Bradley et al., 2013;
Falces et al; 2011; Kim & Han, 2013; Wan et al., 2017; Ziaeian & Fonarow, 2016). These studies
indicate that overall patient education, especially hospital discharge education for those patients
that were recently inpatient, has a profound effect on future exacerbations that lead to
hospitalizations. One randomized control study utilized a HF guideline-based checklist, the
Basoor’s Heart Failure Checklist, in the management of patients which allowed for easy
identification of outpatient resources, current pharmacological based interventions, as well as
identification of missed teaching opportunities (Casteel, 2012; Basoor et al., 2013). This simple
yet effective tool was shown to decrease HF related hospital readmissions from 20% to 2%
within one month (Casteel, 2012). This is suggestive that primary care providers who are aware
of current HF practice guidelines can aid in preventing HF exacerbations in at risk patients.
Patient comprehension
While the difference in care between cardiologists and primary care providers and the
need for patients to be educated about the seriousness of HF is evident, a patient's overall
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comprehension of the presented disease related education also effects their compliance and risk
for hospitalization/readmission (Regalbuto et al., 2014). The Joint Commission on Accreditation
and Health Care Organizations has implemented a standard for discharge instructions known as
HF-1 in an effort to reduce 30-day readmission rates. Included in HF-1 are six topics related to
HF management, which patients should be educated on upon discharge: diet, exercise, weight
monitoring, worsening symptoms, medications and follow-up appointments (Regalbuto et al.,
2014). “Those with a complete understanding of their JC-compliant discharge instructions were
significantly less likely to be readmitted to the hospital within 30 days than those with less than
perfect understanding” (Regalbuto et al., 2014, p.647). So, while all the education
recommendations that were presented by all the studies were similar, this particular study by
Regalbuto et al. was substantially beneficial because it indicated that the interventions without
complete comprehension by the patient may not be statistically beneficial. This revelation leads
back to the importance of patient centered care.
Evidence Based Practice: Verification of Chosen Option
This capstone project utilized a heart failure checklist that is based on a combination of
the Basoor’s Heart Failure Checklist (Appendix B) and the American Heart Association's Target
HF: Heart Failure Discharge Checklist (Appendix C). Providers who utilized the Basoor’s Heart
Failure Checklist were able to reduce the percentage of 30-day hospital readmissions from 20%
to 2% within one month (Casteel, 2012: Basoor et al., 2013). This checklist provides a concise
overview of the most current HF management guidelines and includes “documentation regarding
medication use and its appropriate dose uptitration, relevant education and counseling, and
follow up instructions” (Basoor et al., 2013). This checklist and one similar to it from the
American Heart Association entitled Target HF: Heart Failure Discharge Checklist have shown
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to be beneficial in the prevention of HF exacerbations and improved provider initiated patient
education.
Theoretical Framework or Evidence Based Practice Model
The Rosswurm and Larrabee model for evidence-based practice was used as the
theoretical framework for this capstone project (Appendix D). The model uses theoretical and
research literature related to evidence-based practice, research utilization and change theory to
help guide practitioners into utilizing evidence-based practice to initiate change related to a
potential problem in practice (Rosswurm & Larrabee, 1999). The literature review identified a
strong need for the implementation of evidence-based practice initiatives to improve the
management of heart failure. The Rosswurm and Larrabee model guides “practitioners through
the entire process of changing to evidence-based practice, beginning with the assessment of the
need for the change and ending with the integration of an evidence-based protocol (Rosswurm &
Larrabee, 1999). The model involves a six-step process to incorporate change into practice. The
steps include:
1. Assess the need for change in practice- This step involves collecting internal and external
data, identifying the problem, comparing internal data with external data, and
determining stakeholders. In this step background information is gathered in order to
formulate an organizational gap analysis and problem statement. As previously stated, a
1997 landmark study by Edep et al. determined that there is a significant difference in the
management of HF between cardiologists and primary care providers. With readmission
rates increasingly high for preventable hospitalizations and readmissions of patients with
HF more effective multidisciplinary collaboration and patient centered education are
essential.
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2. Link the problem with the interventions and outcomes- In this step the identified problem
is linked with interventions that produce an outcome indicator. The selection of potential
interventions and patient outcomes are based primarily on clinical judgement, system
priorities and resources (Johnson & Maas, 1998; Rosswurm & Larrabee, 1999). This
capstone project utilized a heart failure checklist that is based on a combination of the
Basoor’s Heart Failure Checklist (Appendix B) and the American Heart Association’s
Target HF: Heart Failure Discharge Checklist (Appendix C).
3. Synthesize best evidence- This step includes the systematic literature review. The
information collected in the review is then critiqued and synthesized with considerations
made to feasibility, benefits and risks for implementation using a standardized worksheet
(Appendix E). In this step the synthesized information is also combined with clinical
judgement, therefore the potential interventions and desired outcomes, such as decreased
readmissions and better management of HF, were major variables when working through
the review of literature. The Rosswurm and Larrabee Worksheet for Critique (Appendix
E) was utilized as an aid in the determination of the level of evidence as proposed by
Melnyk for the projects review of literature.
4. Design a change in practice-In this step, a plan is developed for changing practice using
the evidence-based information retrieved from the previous step. The resources needed
are identified and an implementation process and outcomes are defined. The goal during
this step is to decrease the complexity of the protocol and involve the stakeholders in
developing a pilot. This stage included formulation of the project design. The
stakeholders in this quality improvement project were the patients and providers.
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5. Implementing and evaluating change in practice- In this step the pilot study is
implemented. Once the pilot interventions are in practice for the designated amount of
time a quality improvement study is conducted to evaluate the process and outcomes. The
data collected can then be used to adapt, adopt or reject the proposed changes (Rosswurm
& Larrabee, 1999). This step as it relates to this capstone project began in October 2019
after approval of the project proposal by the University of Massachusetts, Amherst
(UMass) Internal Review Board in late September, 2019.
6. Integrate and maintain change in practice- If the results of the pilot study support a need
for integration of the new practice standards of care then change strategies are initiated
(Rosswurm & Larrabee, 1999). In this step communication is disseminated to all the
stakeholders and education is provided to practitioners. Lastly, the process and outcomes
are continued to be monitored. This step occurred in the last phase of the project and
included surveying the providers (Appendix H) on the benefits of the intervention, in this
case the Heart Failure Management Checklist (Appendix F). Determination was then
made whether or not the checklist can remain as a standard in practice.
The Rosswurm and Larrabee (Rosswurm & Larrabee, 1999) model allows practitioners to
obtain, interpret and integrate research into their practice in a standardized way in order to
promote evidence-based interventions. The use of evidence-based practice will in turn improve
patient health outcomes. The systematic way in which this theoretical model incorporates past
and current research is appealing because of the complexity of cardiac disease and heart failure.
The Rosswurm and Larrabee model allows for a streamlined method of evaluating evidencebased interventions to incorporate into patient care.
Goals, Objectives and Expected Outcomes
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The goal of this capstone project was to visualize, within a primary care setting, a
noticeable reduction of preventable heart failure exacerbations that lead to
hospitalizations/readmissions through multidisciplinary disease management which may
facilitate increased patient knowledge of their disease process. This was evidenced by; patients
signs and symptoms, level of vascular and pulmonary congestion and diagnostic laboratory
values. The objectives for this project were determined utilizing the SMART method (Specific,
Measurable, Assignable, Realistic and Time-specific).
Objective/Goal
Specific

● To ensure that heart failure patients within the practice were
medically managed in accordance with the American Heart
Association, American College of Cardiology and The Heart
Failure of America guidelines.
● To see a 15% increase in the proper management of HF amongst
participants as defined by the guidelines proposed by the
American Heart Association, American College of Cardiology
and The Heart Failure of America.

Measurable

● Pre-intervention and post intervention chart audits of HF patients
were completed. Compliance with current HF guidelines were
assessed.

Assignable

● Patients with a HF diagnosis were determined by the project site
mentor and DNP student.
● Chart reviews pre and post intervention were completed by the
DNP student.
● The DNP student provided a HF management checklist based on
the current guidelines, the Basoor’s Heart Failure Checklist, and
the Target HF: Heart Failure Discharge Checklist.
● A self-developed survey was administered to the practitioners by
the DNP student upon completion of the intervention period.

Realistic

● Patients with a diagnosis of HF require frequent follow up care
and monitoring in order to prevent exacerbations of the disease.
The capstone project took place over a 5-month period of time
which according to national statistics should capture any
hospitalizations for at risk patients.

Time-specific

● The intervention took place over a three-month period of time.
One month prior to the intervention chart reviews and practitioner
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education occurred and one-month post intervention chart audits
and surveys were completed.

Project Design
This capstone quality improvement project was designed as a process improvement
project. In order to collect data a pre-intervention/post-intervention project design was used. To
ensure that providers are practicing within the most current guidelines a self-developed checklist
(Appendix F) based on a combination of the most current American Heart Association
guidelines, the Target HF: Heart Failure Discharge Checklist and the Basoor’s Heart Failure
Checklist were utilized as a resource in every patient exam room for easy reference. Quantitative
data was collected from the participating providers during the post-intervention period of the
project through a Likert Survey (Appendix H). Quantitative data was collected throughout the
pre-intervention and post-intervention periods in the form of participating patient chart audits to
assess if the management of their HF is in accordance with the most current guidelines. The goal
was to see an increase in adherence to guidelines with the use of the self-developed checklist in
the post-intervention phase of the project.
Project Site and Population
The project took place in a private primary care provider group office in Central
Massachusetts. The provider group has two central locations within Worcester County that
currently serve to provide medical care to approximately 8500 patients. According to the United
States Census Bureau the most recent population statistics indicate that Worcester has 185,677
residents, making it the second largest city in New England (2017). The residents of the
community are predominantly White (57.1%), Hispanic (20.9%) and Black (13.2%) as is
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reflected in the clinic’s patient population (United States Census Bureau, 2017). Poverty rates are
noted to be 22.1% with median income of approximately $45,000 (DataUSA, 2019).
Worcester County is noted to be one of the top three counties in Massachusetts where
patients exhibit risky behaviors such as smoking (Figure 1) (DataUSA, 2019). This is
contributory to the high prevalence rates of congestive heart failure hospitalizations and
readmissions within the community (Figure 2 and 3) (DataUSA, 2019). Since Blacks and
Hispanics are at higher risk for heart disease the patient population of the project site served as a
good area for the collection of information.
The project site was comprised of two office locations and three providers with two
nurses and multiple ancillary staff. Services offered include primary care, sports medicine,
pulmonary function testing, electrocardiograms, prolotherapy, ligamental injections, and
intravenous infusions. The project mentor was used as a resource for collecting patient
information for this capstone project.
Barriers and limitations
Barriers to the implementation of my project included the lack of a centralized list of
cardiac patients, lack of appointment reason specification on scheduling templates and high
volume of patients per provider per day. In order to overcome these barriers I utilized the
knowledge of the patient population that my project site mentor had in compiling a participant
list appropriate for my project. To curve the time restraints of the providers, I made my
guidelines checklist and educational information as concise and straightforward as possible while
still articulating all the main points.
Methods
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This capstone project occurred over a five-month period of time in three separate phases.
In the first phase the project site mentor and the DNP student identified eligible participants
within the primary care practice in accordance with the problem statement. Once participants had
been identified the DNP student performed a pre-intervention chart audit of the patients. Using
the self-developed checklist (Appendix F) and a laboratory and diagnostic test review the DNP
student determined if patient’s HF management was in accordance with the most recent
guidelines. Determination was made if all outpatient resources were being utilized in accordance
with the checklist recommendations.
Once a thorough chart audit was complete, and participants were identified a 30-minute
information session with the practitioners in the primary care setting took place. The providers
were educated on the current American Heart Association, American College of Cardiology and
The Heart Failure of America guidelines as well as use of the checklist. Phase one of the project
occurred over a one-month timespan. A simplified PowerPoint presentation explaining
background information on HF and the problem statement and evidence-based practice for this
project was presented to the providers (Appendix G).
Phase 2 of the capstone project involved implementation of the checklist into daily
practice. The checklist was placed in each patient exam room as a reference source for the
providers. The expectation was that when a HF patient presented to the clinic for a follow up the
provider utilized the checklist to ensure that current practice guidelines and medication
recommendations are being met with care. The DNP student contacted each provider within the
practice monthly during this phase to ensure implementation and to gather feedback. This phase
took place over a 4-month period of time.
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The final phase of the project was the data gathering phase. The DNP student performed
a post intervention chart audit on the HF patients that were identified as participants in phase 1.
The chart audit took place in the same manner as in Phase 1 of the project. Once the chart audit
was complete and all data was compiled the information was analyzed and interpreted. Lastly,
the providers were asked to take a survey to gage whether the intervention was beneficial to their
practice.
Measurement Instruments
In order to measure the outcomes of this DNP project the following instruments were
used: The Heart Failure Management Checklist (Appendix E) and the Likert Scale for Project
Efficacy (Appendix H). The Likert Scale for Project Efficacy is a self-developed scale that will
assessed the providers thoughts on the project intervention and whether or not the tool, the Heart
Failure Management Checklist, was beneficial and sustainable within their practice. This survey
was administered post-intervention.
The Heart Failure Management Checklist that was utilized for this project is a selfdeveloped checklist based off of the Basoor’s Heart Failure Checklist and the Target HF: Heart
Failure Discharge Checklist. Both checklists have been proven effective as noted in the review of
literature, at reducing hospitalizations for patients with HF. This checklist was used to determine
the percentage of compliance with current HF guidelines within the participating patients group
as well as the tool used throughout the intervention period of the project. The DNP student
completed a pre-intervention and post-intervention chart audit based on guidelines addressed on
The Heart Failure Management Checklist to gage percentage of adherence.
Data Collection Procedures
Plan
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The objective of this capstone project was to ensure that heart failure patients within the
project site primary care practice are medically managed in accordance with the American Heart
Association, American College of Cardiology and The Heart Failure of America guidelines. It
was expected that through the implementation of The Heart Failure Management Checklist that
there would be a 15% increase in the proper management of HF amongst participants. Projected
recruitment for this project is set at 10 patients aged 65 and older with a HF diagnosis stages A-C
and class I-III.
Do
The capstone project was implemented over a 5-month period of time in three distinct
phases. Phase 1 was the pre-intervention phase where participants were recruited and data about
their current treatment plan and overall state of health was gathered through chart audits. An
informational session was provided to the practitioners regarding the implementation tool, The
Heart Failure Management Checklist, and current HF treatment guidelines.
In phase 2 the checklist was implemented for a three-month period of time across all
three providers. It was the expectation that the providers are using the checklist as a tool for
guiding treatment of HF patients and a method if initiating patient education.
In phase 3, data was gathered using a Likert Survey that was provided to the practitioners
and post intervention chart audits completed in the same manner as phase 1. In this final phase
all the collected data was analyzed and compared with the pre-intervention phase data as well as
expected outcomes. Phase 1 and 3 of the project are each expected to last one month.
Check
All the data that was collected during Phase 1 and Phase 3 was analyzed and interpreted
using descriptive statistics. The collected data was interpreted to check if the objectives of the
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project were met, if the tool used was beneficia,l and if there was an improvement in the
adherence to current guidelines for HF patients treatment plans. It should be noted that the DNP
student checked in at least twice monthly with the practitioners in order to gage compliance and
use of the tool during the implementation period.
Act
Once all the data had been assessed and interpreted a determination was made if the
checklist provided through this capstone project is sustainable within the primary care practice.
Limitations and strengths were identified to determine if adjustments in the project should be
made.
Data Analysis
The data that was collected during this capstone project was discrete quantitative data.
The quantitative data was analyzed using descriptive statistics. Graphical representations in the
form of simple bar graphs were used to analyze the information collected through the project. In
order to determine where the differences in adherence to guidelines occur, data that was
collected from the checklist was separated into four categories for analysis; medication,
interventions, counseling and follow up care. It was then determined where the greatest
disparities lie. A total percentage of guideline adherence were calculated pre and post
intervention. Graphical representations of pre and post intervention adherence percentages were
provided for all three categories.
Timeline
The capstone project proposal was submitted and approved by the University of
Massachusetts, Amherst (UMass) Internal Review Board in September 2019. Participant
recruitment began in October 2019 and the intervention phase took place from November 2019
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through January 2020. Data analysis and dissemination of information occurred in February
2020. Please refer to Appendix J for a complete project timeline.
Ethical Considerations and Protection of Human Subjects
The University of Massachusetts, Amherst (UMass) Internal Review Board (IRB)
approval was obtained prior to initiating the DNP Project. The medical and health information of
the patients that participated in this project was protected under the Health Insurance Portability
and Accountability Act of 1996 (HIPAA) (U.S.Department of Health and Human Services,
2017). The DNP student and all practice personnel who were involved in conducting this project
adhered to the Standards of Care as established by the primary care practice. All information that
was collected for the purpose of evaluating the efficacy and impact of this project was
aggregated patient data without any patient identifiers.
The risk to patients participating in this capstone project was not different from patients
receiving standard cardiac care. Confidentiality was maintained by assigning a non-identifying
code to each participant. The list of participating patients and their respective codes was
electronically stored and only accessible by the DNP student and project site mentor. All
electronic files and data collected from chart auditing was password protected to prevent
unauthorized users.
Data Analysis
Results
The quality improvement project took place at a private primary care provider group in
Central Massachusetts. It was completed through a three-phase project design and spanned a
five-month period of time. The recruited participants were male and female patients aged 65 and
older with a diagnosis of heart failure Class I-III and Stage A-C. Initially 13 participants were
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identified as appropriate for data collection. However, subsequently one participant had to be
excluded because their disease process quickly worsened changing his NYHA classification.
Five female and seven male White and Hispanic patients were identified as appropriate
participants for data collection. The overall goal of the project was to see a 15% increase in the
proper management of HF amongst participants as defined by the guidelines proposed by the
American Heart Association, American College of Cardiology and The Heart Failure of
America.
Prescriptive practice
Primary care adherence to the recommended prescriptive guidelines can be directly
linked to medication reconciliation and maintenance lab work follow ups. Figure 4 demonstrates
data collected using the Heart Failure Checklist on the pharmaceutical management of HF. One
participant had a documented allergy to angiotensin converting enzyme inhibitors (ACE-I),
however they were not prescribed an angiotensin II receptor blocker (ARB) in its place as
recommended by the American Heart Association (American Heart Association, 2013).

Figure 4: Primary care adherence to recommended prescriptive guidelines
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Two participants with left ventricular systolic dysfunction (LVSD), as noted with an
ejection fraction (EF) of <35% and creatinine levels of <2.0, qualified for aldosterone therapy
with spironolactone however the indicated medication was not prescribed. Hydralazine/nitrate
and digoxin therapy were excluded from the findings as they did not apply to the participant
patient population or were not prescribed to any participants during the time of the project. One
participant with a history of paroxysmal atrial fibrillation was managed by flecainide, rather than
digoxin, and anticoagulants.
ACE inhibitor use increased by 42% in the post intervention group, while ARB use
increased by 9%. The providers first line of treatment was beta blocker therapy in the medical
management of heart failure. The use of beta blockers, especially metoprolol succinate, was high
amongst the participant group and remained unchanged pre and post intervention.
One participant was on warfarin and regularly attended the anticoagulation clinic. Most
other participants were prescribed Xarelto, Pradaxa or Eliquis for anticoagulation. The
prescriber's increased aspirin use by 8% post-intervention to patients not on another form of
anticoagulation. One participant was placed on Xarelto and aspirin without proper medication
reconciliation pre-intervention. This participant still had both medications prescribed during
post-intervention chart review. Overall medication reconciliation did improve by 25% postintervention (Figure 5).
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Figure 5: Primary care adherence to recommended intervention guidelines

Medical intervention and follow up service guidelines
Smoking cessation was not included in the intervention data because during the time of
the quality improvement project the providers did not complete any smoking cessation
interventions to the participants of the project. Four out of the twelve participants were current
everyday smokers while all others never smoked, therefore no intervention was warranted.
Two participants were hospitalized during the intervention phase of the quality
improvement project. Of the two hospitalized participants one had his first echocardiogram while
inpatient despite being diagnosed with HF for many years. The participant was also not routinely
monitored by a cardiologist prior to his hospitalization. While all of the other patients had past
echocardiograms noted upon chart audits (Figure 5), 45% of the ultrasounds were outdated by at
least over one year. Post-intervention chart audits indicated that three participants were
scheduled for follow up echocardiograms (Figure 6) and one of the three had received their
ultrasound during the intervention phase. Furthermore, referrals for cardiology appointments

HEART FAILURE: PREVENTING HOSPITALIZATIONS

29

increased by 25% which is favorable. Of the participants two patients were noted to be
noncompliant with cardiology follow up care by missing scheduled appointments.

Figure 6: Primary care adherence to follow up care guidelines

Most concerning while completing the pre-intervention chart audits was the lack of blood
pressure, dyslipidemia and glucose control present in the participant population (Figure 5). All
participants were diagnosed with hyperlipidemia and only one participant did not have a
diagnosis of diabetes. Two participants were on two or more hyperlipidemia medications despite
not having proper lipid control or follow up maintenance labs (Figure 6). For the diabetic
participants there was a 17% increase in A1C control post intervention, however many
participants were still displaying A1C readings of >7.0, with one participant at a 10.2 only
receiving management with metformin. There was a 25% increase in the scheduling of
maintenance labs to monitor patients’ conditions post intervention, however even with the
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medication reconciliation improved (25%) there was still a lack of follow through for many
participants.
Blood pressure control was a complex intervention to audit during the pre and post
intervention periods. While many participants showed blood pressure control at one time or
another the overall management was at best borderline even with a 17% increase in control noted
during the post-intervention audits. The lack of complete blood pressure control can be attributed
to the prescriptive data presented in figure 4 and lack of ongoing disease management counseling
indicated in Figure 7.
Counseling guidelines
Primary care recommended patient counseling guidelines were lacking during the preintervention phase, and while there was a significant percentage of increases across all
counseling interventions noted in the post-intervention audits, there was still room for
improvement looking at the overall picture. Chart documentation pre-intervention indicated that
only one of the participants was counseled on the need for a sodium restricted diet, fluid
restriction and the importance of daily weights (Figure 7). Furthermore, while six participants
qualified for weight reduction counseling based on their current body mass index (BMI) no preintervention counseling was noted in their charts.
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Figure 7: Primary care adherence to counseling guidelines

Education and counseling regarding maintaining fluid restrictions, completing daily
weights to monitor for fluid overload and the need for weight reduction improved by 17% after
the intervention period. Sodium restriction and dietary counseling increased by 34% postintervention and physical activity recommendations and counseling on the importance of
remaining active increased by 42%. While this data does suggest a shift towards practicing
within the recommended guidelines, it still is only representative that less than half (42%) of the
participants are educated and counseled appropriately.
Project efficiency survey
Once the intervention phase was complete the two participating providers were
administered a Likert Scale for Project Efficiency (Appendix H) survey (Figure 8). The survey
was administered during a debriefing meeting with the providers where feedback on the project
occurred.
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Figure 8: Results of the Likert Scale for Project Efficiency Survey

The results of the survey and verbal feedback from the providers was positive. Both of
the participating providers found the Heart Failure Checklist to be beneficial for aiding in the
patients plan of care and real time patient education. Comments regarding the ease of use of the
checklist while still positive, were mixed. One provider thought while the checklist was thorough
it was lengthy, while the other provider had no issues with ease of use. Both providers indicated
that while they may not use the checklist with each patient due to time restraints, having the tool
in the exam room as a reference guide is useful and therefore they will continue to keep the
checklist at the work stations.
Discussion
Data collected for this quality improvement project indicates that there is a gap present
between the recommended guidelines and actual practice in the primary care management of
patients with heart failure. Results from the pre-intervention chart audits exhibited that there
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were areas on the Heart Failure Checklist that patients plan of care were lacking. Specifically, in
the frequency of updated monitoring echocardiograms, pharmaceutical management of heart
failure and comorbid disease processes, review of routine lab work for medication management
adjustments, education on dietary restrictions and the importance of daily weights. Counseling
interventions were overlooked in favor of management with medications.
The results of the project are consistent with the literature review findings. Research
indicates that despite ongoing efforts there still remains a gap in the multidisciplinary
management of HF that is inclusive of the patient. With that said, overall treatment of heart
disease was improved in patients that routinely followed up with a cardiologist (Falce et al.,
2011). The participants of the project were either not consistently monitored by a cardiologist,
were noncompliant with specialist follow up, or in the case of one patient that was hospitalized,
had not established care with a cardiologist. Multidisciplinary communication was lacking, as
evidenced by the completed chart audits. In many instances there was no routine communication
from the cardiologist to the primary care provider. This aspect of poor communication led to a
fragmentation of information, especially relating to echocardiogram dating and lab results.
Routine follow up care, which is inclusive of patient education, medication management
and laboratory maintenance is imperative to maintaining health. Interventions inclusive of direct
human factors, such as repeated assessments and follow ups care, as well as patient education
centered around the HF disease process, proper nutrition and exercise have shown to have
significant positive therapeutic outcomes on HF patients at risk for repeated hospitalizations
(Wan et al., 2017). Post-intervention chart audits did reveal an upward trend in compliance with
recommended guidelines, and while the targeted 15% improvement was met in many cases, there
were still many areas that were lacking post-intervention that could have served beneficial to
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patient care. For example, while the primary care providers were not hesitant about prescribing
beta blockers, many patients were not on an ACE-I or an ARB which are strongly recommended
by The American Heart Association for decreasing HF progression, hospitalizations and
mortality rates (American Heart Association, 2013). This may be attributed to provider concern
for hyperkalemia, interactions with other medications or patient reported side effects of cough.
Incidence estimates of ACE-I and/or ARB associated hyperkalemia vary, however up to 10% of
patients (increased for those with renal insufficiency) can experience increased potassium levels
(Raebel, 2012).
Furthermore, the management of patients with diabetes and hyperlipidemia, while
improved post-intervention 8% and 17% respectively, still had room for further improvement.
Many patients followed up with the primary care providers for episodic complaints which were
addressed in real time. However, a lack of consistent medication reconciliation and chart review
for patients with chronic diseases, caused lab monitoring to be overlooked.
The theoretical framework utilized for this capstone project was the Rosswurm and
Larrabee model for evidence-based practice. The model involves a six-step process to
incorporate change into practice. The steps include; assessing the need for change in practice,
linking the problem with the interventions and outcomes, synthesizing best evidence, designing a
change in practice, implementing and evaluating the change in practice, and lastly integrating
and maintaining the change into practice (Rosswurm & Larrabee, 1999). This particular
theoretical framework is the foundation on which the three phases of this capstone project was
built upon. The project design and methods section of the proposal go hand in hand with the six
stages of the Rosswurm and Larrabee model.
Cost-Benefit Analysis
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The total expected expenses for this quality improvement project were expected to be
streamlined by utilizing donated time from the project coordinator/DNP student and salary-based
providers within a primary care practice. The project site mentor for this DNP student also
offered to volunteer her time to help facilitate participant recruitment. Printing and travel
expenses are indicated in Appendix I. Non-monetary benefits of the quality improvement project
include increased provider education surrounding the current recommendations and guidelines
for heart failure treatment which lead to improved medical management of HF patients and
decreased mortality and morbidity. A post intervention provider appreciation gift was given to
the three participating providers for their time and assistance with this capstone project.
Strengths and Limitations
The success of the quality improvement project was fully dependent on stake holder,
specifically the provider, interest and willingness to utilize the Heart Failure Checklist in the
clinical setting. During phase one of the project one of the three participating providers went on
maternity leave, yielding only two providers to participate in the utilization of the Heart Failure
Checklist. Initially it was thought that this would be problematic for the project, however the two
participating providers, one of which is the project site mentor, were very supportive and
invested.
Many strengths can be appreciated through the implementation of the Heart Failure
Checklist. The participating providers were updated on the most recent HF treatment guidelines
and through the use of the checklist cardiology follow ups, echocardiograms, maintenance labs,
vaccination compliance, management of comorbidities and medications all improved. The Heart
Failure Checklist tool proved to be beneficial in aiding the providers to make advisable changes
to patients plan of care and disease management and in line with information gathered in the

HEART FAILURE: PREVENTING HOSPITALIZATIONS

36

review of literature. The Basoor’s Heart Failure Checklist, one of the tools that this projects
checklist was based on, has shown to decrease HF related hospital readmissions from 20% to 2%
in just one month (Casteel, 2012). Therefore, primary care providers who are up to date on the
current HF practice guidelines have a great potential to facilitate the prevention of
hospitalizations for stable patients using such checklist tools.
Limitations in the project stemmed from provider time restraints due to heavy patient
caseloads and understaffing. This in turn did not allow for adequate time to review all of the
guidelines on the checklist with appropriate HF patients. Post-intervention debriefing indicated
that one of the two providers stated that the checklist was lengthy indicating a difficulty of use.
Interventions and project modifications can be made accordingly if the project was to be
completed on a larger scale, including involving the electronic medical record provider to help
streamline some data points.
Conclusion
Heart failure is one of the leading causes of hospitalizations and readmissions nationally.
Exacerbations of the disease that lead to hospitalizations are shown to have a negative impact on
overall patient mortality and morbidity. The economic and physical burden of repeated
hospitalizations and the management of heart failure on patients is immense. Primary care
providers act as the “gatekeepers” between their patients and other members of the
multidisciplinary team. Improved integrative care between cardiologists and primary care
providers can lead to improved patient outcomes. Primary care providers should have greater
access to HF guidelines in an effort to bridge the gap in knowledge between practitioners.
Utilizing the recommendations and guidelines, as imposed by the American Heart Association,
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American College of Cardiology, and The Heart Failure of America leads to improved patient
outcomes for those with a diagnosis of heart failure.
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Appendix A- Heart Failure Diagnosis Classification/Staging
New York Heart Association (NYHA)
Classification

American College of Cardiology/American
Heart Association Guidelines

Class I

Patients with heart
Stage 1
disease without
resulting limitation of
physical activity.
Ordinary physical
activity does not
cause HF symptoms
such as fatigue or
dyspnea.

No objective
evidence of
cardiovascular
disease. No
symptoms and no
limitation in ordinary
physical activity.

Class II

Patients with heart
Stage 2
disease resulting in
slight limitation of
physical activity.
Symptoms of HF
develop with ordinary
activity but there are
no symptoms at rest.

Objective evidence of
minimal
cardiovascular
disease. Mild
symptoms and slight
limitation during
ordinary activity.
Comfortable at rest.

Class III

Patients with heart
disease resulting in
marked limitation of
physical activity.
Symptoms of HF
develop with less
than ordinary
physical activity but
there are no
symptoms at rest.

Stage 3

Objective evidence of
moderately severe
cardiovascular
disease. Marked
limitation in activity
due to symptoms,
even during less-thanordinary activity.
Comfortable only at
rest.

Class IV

Patients with heart
disease resulting in
inability to carry on
any physical activity
without discomfort.
Symptoms of HF
may occur even at
rest.

Stage 4

Objective evidence of
severe cardiovascular
disease. Severe
limitations.
Experiences
symptoms even while
at rest.
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Table 1: Review of Literature Database Search Results

Database
Cochrane

PubMed

CINAHL

Congestive heart
failure management

3

9855

61

Heart failure
readmission

6

1241

722

Readmission
prevention for heart
failure

1

69

6

Hospitalization
prevention heart
failure

43

574

4

Primary care of
heart failure

44

2859

220
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Appendix F: Heart Failure Management Checklist

MEDICATIONS
ACE Inhibitor (if LVSD)
ARB (if LVSD and ACE not tolerated)
β-Blocker (if LVSD, use only carvedilol,
metoprolol succinate, or bisoprolol)
Aldosterone antagonist (if LVSD, Cr
≤2.5 in men, ≤2.0 women, and patients
potassium and renal function will be
closely monitored)
Hydralazine/nitrate (if self identified
African American and LVSD)
Digoxin (if Atrial Fibrillation or
refractory symptoms)
Nitrates (as needed or indefinite or both)
Anticoagulation for atrial fibrillation or
flutter (permanent or paroxysmal) or
other indications
Aspirin
Lipid lowering agents
Diuretics
INTERVENTIONS
Most recent left ventricular ejection
fraction (__________%)
Date of most recent LVEF
(__________)
Pneumococcal vaccination administered
Influenza vaccination administered
Blood pressure controlled (<140/90)

Yes

No

Not
Reason Not
Indicated Done/Contraindications

HEART FAILURE: PREVENTING HOSPITALIZATIONS

Dyslipidemia control
Glucose/Diabetic control
Medication reconciliation
Smoking cessation
COUNSELING
Sodium restricted diet
Fluid restriction if indicated
Monitoring daily weights
Weight reduction counseling if indicated
Physical activity counseling
Importance of compliance with
appointments and treatment plan
FOLLOW UP SERVICES
Cardiologist follow up
Primary care follow up
Cardiac rehabilitation
Echocardiogram
Anticoagulation service follow up
Maintenance lab work follow up (lipid
profile, electrolytes, kidney function)
The American Heart Association, 2013
Basoor et al., 2013
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Appendix G: Informational Presentation for Providers
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Appendix H: Likert Scale for Project Efficacy

Statement
1. I found the information about
the most recent heart failure
guidelines and recommendations
beneficial to practice.
2. I found the checklist to be user
friendly.
3. I found the checklist helpful in
aiding to establish a plan of care.
4. The checklist prompted patient
education.
5. The checklist is a tool I can
continue to use in practice.

Strongly Agree
Agree

Neither

Disagree

Strongly
Disagree
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Figure 1: Risky and Harmful Behavior Rates in Massachusetts
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Figure 2: Prevalence of Pneumonia, Heart Failure and Heart Disease

57

HEART FAILURE: PREVENTING HOSPITALIZATIONS
Figure 3: Readmission Rates for Heart Failure, Pneumonia and Heart Disease
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Appendix I: Project Cost Analysis
Personnel/Interventions

Cost

Program coordinator/DNP student time for
implementation of project

Donated time

Project site mentor assistance

Donated time

30-minute provider education session

Salaried/Donated time

Printing fees

$50

Transportation fees for DNP student to travel
between the two clinic locations

$50

Post project provider appreciation gifts

$100

Total Estimated Cost of Quality Improvement Project: $200
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Appendix J: Project Timeline

September October
Proposal
Approval
Recruitment
of eligible
participants
Preintervention
chart audits
Assess
baseline
percentage
of patient
management
within HF
guidelines
DNP student
guided
education
session on
the
intervention
checklist
Utilization
of the
intervention
checklist
Post
intervention
chart audit
Assess post
intervention
percentage
of patient
management
within HF

November December January

February
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guidelines
Administer
Likert
Survey to
Providers
Data
analysis of
results
Completion
of Project
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